Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overview and new technology in cyclodestructive procedures

J Fishbaugh

    Insight (American Society of Ophthalmic Registered Nurses)
    |December 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Isolating a pure population of epidermal stem cells for use in tissue engineering.

    Experimental dermatology·2001
    Same author

    High technology for low vision.

    Insight (American Society of Ophthalmic Registered Nurses)·1996
    Same author

    Look who's driving now--visual standards for driver licensing in the United States.

    Insight (American Society of Ophthalmic Registered Nurses)·1995
    Same author

    Nursing care of the patient with cornea graft rejection.

    Insight (American Society of Ophthalmic Registered Nurses)·1995
    Same author

    Subconjunctival hemorrhage--something more you should know.

    Insight (American Society of Ophthalmic Registered Nurses)·1995
    Same author

    Negotiating the nurse research coordinator role.

    Insight (American Society of Ophthalmic Registered Nurses)·1995
    Same journal

    Optimising Vision in Aged Care Facilities: Professional Knowledge About Glaucoma.

    Insight (American Society of Ophthalmic Registered Nurses)·2018
    Same journal

    Assessing Visual Impairments in Stroke Patients.

    Insight (American Society of Ophthalmic Registered Nurses)·2018
    Same journal

    Eyes: 15 Facts You Probably Didn't Know About Them.

    Insight (American Society of Ophthalmic Registered Nurses)·2018
    Same journal

    Man versus Mother Nature: Case Study of a Fungal Eye Infection.

    Insight (American Society of Ophthalmic Registered Nurses)·2018
    Same journal

    Multisensory Eyedrop Bottle Sleeves for Better Identification of Eyedrops: A Low Vision Aid to Improve Medication Adherence.

    Insight (American Society of Ophthalmic Registered Nurses)·2018
    Same journal

    Atypical Optic Neuritis: Neuromyelitis Optica and Other Causes.

    Insight (American Society of Ophthalmic Registered Nurses)·2018
    See all related articles

    A new semiconductor diode laser technology, the IRIS Medical G-Probe, offers a promising alternative for severe glaucoma patients when other treatments fail to lower intraocular pressure (IOP). This cyclophotocoagulation therapy may be a superior option for reducing aqueous production.

    Area of Science:

    • Ophthalmology
    • Medical Technology
    • Glaucoma Treatment

    Background:

    • Severe glaucoma often requires interventions to reduce intraocular pressure (IOP) when medical and surgical options are insufficient.
    • Cyclodestructive procedures aim to decrease aqueous humor production to manage refractory glaucoma.
    • Traditional cyclodestructive techniques have limitations, driving the search for improved methods.

    Purpose of the Study:

    • To introduce and evaluate a novel cyclophotocoagulation therapy utilizing the IRIS Medical G-Probe and a semiconductor diode laser.
    • To assess the potential of this new technology as a superior alternative for managing severe, uncontrolled glaucoma.

    Main Methods:

    • The study focuses on the application of the IRIS Medical G-Probe with a semiconductor diode laser.

    Related Experiment Videos

  • This technology is a form of cyclophotocoagulation therapy.
  • The procedure targets the reduction of aqueous production in the eye.

    • Main Results:

    • The IRIS Medical G-Probe, coupled with a semiconductor diode laser, has received FDA approval.
    • This technology represents a new advancement in cyclophotocoagulation.
    • It is presented as a potentially superior alternative to existing cyclodestructive procedures.

    Conclusions:

    • The IRIS Medical G-Probe offers a new therapeutic option for patients with severe glaucoma unresponsive to other treatments.
    • This semiconductor diode laser technology may provide enhanced efficacy and safety in reducing intraocular pressure.
    • Further clinical evaluation is warranted to establish its long-term benefits compared to traditional methods.